Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo

Objective: The objective of the present study is to investigate the anti-proliferation activity of Astragalus on human hepatocellular carcinoma (HCC) cells and its mechanism. Materials and Methods: Hepatic cancer H22 bearing mice were used to study the anti-hepatocarcinoma activity of Astragalus in vivo. The growth curve and inhibitory rate of tumor growth were measured. Cell apoptosis of each group was measured by flow cytometry (FCM). Protein expression of Bax and Bcl-2 were analyzed by immunohistochemistry (IHC). The Statistical Package for Social Sciences version 13.0 (SPSS Inc, Chicago, IL) was used for standard statistical analysis including one-way ANOVA and Student's t-test. A value of P<0.05 was considered to be statistically significant. Results: Astragalus significantly inhibited the growth of H22 carcinoma, with an inhibitory rate of 17.28-52.36%. FCM and immunohistochemical assay show that the cell apoptosis rate and protein expression of Bax and Bax/Bcl-2 ratio of H22 transplanted tumor in Astragalus treated group were significantly higher than the control group (P<0.05). The protein expression of Bcl-2 was significantly lower than control (P<0.05). Conclusion: The results of the present study suggest that Astragalus has significant anti-tumor effect in vivo in inducing apoptosis of H22 tumor cells by promoting protein expression of Bax, decreasing protein expression of Bcl-2 gene, and markedly increasing the Bax/Bcl-2 ratio.

[1]  W. Ji,et al.  Antitumor and immunoregulatory effects of astragalus on nasopharyngeal carcinoma In Vivo and In Vitro , 2011, Phytotherapy research : PTR.

[2]  S. B. Prasad,et al.  Cyclophosphamide and ascorbic acid-mediated ultrastructural and biochemical changes in Dalton's lymphoma cells in vivo. , 2010, European journal of pharmacology.

[3]  C. Cho,et al.  Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. , 2010, International journal of molecular medicine.

[4]  R. Ralhan,et al.  Clinical significance of TC21 overexpression in oral cancer. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[5]  L. Moretti,et al.  Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model , 2009, Clinical Cancer Research.

[6]  Jing Liu,et al.  Nitric Oxide Induces Cell Death by Regulating Anti-Apoptotic BCL-2 Family Members , 2009, PloS one.

[7]  W. Gedroyc,et al.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics , 2009, Expert review of gastroenterology & hepatology.

[8]  Jia Ye,et al.  Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice , 2009, BMC complementary and alternative medicine.

[9]  Z. Gu,et al.  Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. , 2009, Journal of ethnopharmacology.

[10]  Xi-ping Zhang,et al.  Protective effect of Radix Astragali injection on immune organs of rats with obstructive jaundice and its mechanism. , 2009, World journal of gastroenterology.

[11]  K. Auyeung,et al.  Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line. , 2009, International journal of molecular medicine.

[12]  C. Cho,et al.  Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. , 2007, Carcinogenesis.

[13]  S. Sen,et al.  Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. , 2006, Anticancer research.

[14]  Alexandrina Burlacu,et al.  Regulation of apoptosis by Bcl‐2 family proteins , 2003, Journal of cellular and molecular medicine.

[15]  D. Green,et al.  A Matter of Life and Death , 2008, Science.

[16]  Guangyong Chen,et al.  Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats , 2002, Cancer Chemotherapy and Pharmacology.

[17]  J C Reed,et al.  Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.

[18]  Z. Oltvai,et al.  Bcl-2 gene family and the regulation of programmed cell death. , 1994, Cold Spring Harbor symposia on quantitative biology.

[19]  R. K. Zee-Cheng.  Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. , 1992, Methods and findings in experimental and clinical pharmacology.

[20]  P. Brissot,et al.  [Non surgical treatment of hepatocellular carcinoma]. , 1992, La Revue du praticien.

[21]  J Salvage,et al.  A matter of life and death. , 1981, Nursing times.